Please login to the form below

Not currently logged in
Email:
Password:

New Accounts: June

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period March to May 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period March to May 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com.

Alchemy

Corporate

Corporate

Seven Stones

AstraZeneca

Faslodex

Breast cancer

The Medical Multimedia Company

Boehringer Ingelheim

N/A

N/A

Dark Horse Agency

Ferring

NPD

Urology

FCB Healthcare

Genzyme

Thyrogen

Oncology

Big Blue

Gilead Sciences

Emtriva

HIV

FCB HealthCare

Gilead Sciences

Truvada

HIV

FCB HealthCare

Gilead Sciences

Viread

HIV

FCB HealthCare

Gilead (International)

Corporate

HIV

FCB HealthCare

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Intervet

Ibaflin gel

Antibiotic

Woolley Pau

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Roche

Avastin

Colorectal cancer

MJL Advertising

Roche (International)

NPD

Haematology

FCB HealthCare

Trinity-Chiesi Pharmaceuticals

New products

Respiratory portfolio

Swordfish Advertising

Vernacare

Portfolio

Infection control

Mason Zimbler



2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics